Malaria parasitemia among blood donors in Uganda.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
05 2020
Historique:
received: 24 10 2019
revised: 17 02 2020
accepted: 17 02 2020
pubmed: 14 4 2020
medline: 9 9 2020
entrez: 14 4 2020
Statut: ppublish

Résumé

Malaria remains a leading transfusion associated infectious risk in endemic areas. However, the prevalence of malaria parasitemia has not been well characterized in blood donor populations. This study sought to determine the prevalence of Plasmodium in red blood cell (RBC) and whole blood (WB) units after the rainy season in Uganda. Between May and July 2018, blood was collected from the sample diversion pouch of 1000 WB donors in Kampala and Jinja, Uganda. The RBC pellet from ethylenediamine tetraacetic acid (EDTA) anticoagulated blood was stored at -80°C until testing. DNA was extracted and nested PCR was used to screen samples at the genus level for Plasmodium, with positive samples further tested for species identification. Malaria parasitemia among asymptomatic, eligible blood donors in two regions of Uganda was 15.4%; 87.7% (135/154) of infections were with P. falciparum, while P. malariae and P. ovale were also detected. There were 4.3% of blood donors who had mixed infection with multiple species. Older donors (>30 years vs. 17-19 years; aPR = 0.31 [95% CI = 0.17-0.58]), females (aPR = 0.60 [95% CI = 0.42-0.87]), repeat donors (aPR = 0.44 [95% CI = 0.27-0.72]) and those donating near the capital city of Kampala versus rural Jinja region (aPR = 0.49 [95% CI = 0.34-0.69]) had a lower prevalence of malaria parasitemia. A high proportion of asymptomatic blood donors residing in a malaria endemic region demonstrate evidence of parasitemia at time of donation. Further research is needed to quantify the risk and associated burden of transfusion-transmitted malaria (TTM) in order to inform strategies to prevent TTM.

Sections du résumé

BACKGROUND
Malaria remains a leading transfusion associated infectious risk in endemic areas. However, the prevalence of malaria parasitemia has not been well characterized in blood donor populations. This study sought to determine the prevalence of Plasmodium in red blood cell (RBC) and whole blood (WB) units after the rainy season in Uganda.
METHODS AND MATERIALS
Between May and July 2018, blood was collected from the sample diversion pouch of 1000 WB donors in Kampala and Jinja, Uganda. The RBC pellet from ethylenediamine tetraacetic acid (EDTA) anticoagulated blood was stored at -80°C until testing. DNA was extracted and nested PCR was used to screen samples at the genus level for Plasmodium, with positive samples further tested for species identification.
RESULTS
Malaria parasitemia among asymptomatic, eligible blood donors in two regions of Uganda was 15.4%; 87.7% (135/154) of infections were with P. falciparum, while P. malariae and P. ovale were also detected. There were 4.3% of blood donors who had mixed infection with multiple species. Older donors (>30 years vs. 17-19 years; aPR = 0.31 [95% CI = 0.17-0.58]), females (aPR = 0.60 [95% CI = 0.42-0.87]), repeat donors (aPR = 0.44 [95% CI = 0.27-0.72]) and those donating near the capital city of Kampala versus rural Jinja region (aPR = 0.49 [95% CI = 0.34-0.69]) had a lower prevalence of malaria parasitemia.
CONCLUSIONS
A high proportion of asymptomatic blood donors residing in a malaria endemic region demonstrate evidence of parasitemia at time of donation. Further research is needed to quantify the risk and associated burden of transfusion-transmitted malaria (TTM) in order to inform strategies to prevent TTM.

Identifiants

pubmed: 32282944
doi: 10.1111/trf.15775
pmc: PMC7908807
mid: NIHMS1665312
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-964

Subventions

Organisme : National Institute of Allergy and Infectious Diseases
ID : T32AI102623
Pays : International
Organisme : National Institute of Allergy and Infectious Diseases
ID : R01AI128779
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI120938
Pays : United States
Organisme : U.S. Department of Defense Peer Reviewed Medical Research Program
ID : W81XWH1810742
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI128779
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI102623
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL151826
Pays : United States

Informations de copyright

© 2020 AABB.

Références

Malar J. 2017 Aug 7;16(1):319
pubmed: 28784119
Malar J. 2012 Jan 31;11:29
pubmed: 22289302
Am J Trop Med Hyg. 2006 Aug;75(2):219-25
pubmed: 16896122
Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):82-99
pubmed: 18342279
Transfusion. 2018 Apr;58(4):836-839
pubmed: 29633320
N Engl J Med. 2001 Jun 28;344(26):1973-8
pubmed: 11430326
Transfusion. 2019 Jan;59(1):412-427
pubmed: 30615810
Vox Sang. 2018 Jan;113(1):3-12
pubmed: 29193128
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Trials. 2018 Nov 6;19(1):610
pubmed: 30400934
Lancet. 2016 Apr 23;387(10029):1753-61
pubmed: 27116282
Trans R Soc Trop Med Hyg. 2006 Jul;100(7):615-22
pubmed: 16551469
J Clin Microbiol. 2014 Feb;52(2):387-91
pubmed: 24478466
Malar J. 2015 Dec 30;14:528
pubmed: 26714465
Open Forum Infect Dis. 2019 Jun 11;6(7):ofz283
pubmed: 31334300
Emerg Infect Dis. 2015 Oct;21(10):1853-7
pubmed: 26401635
Acta Trop. 2012 Mar;121(3):184-95
pubmed: 21420377
Lancet Infect Dis. 2012 Mar;12(3):191-200
pubmed: 22172305
Methods Mol Med. 2002;72:189-203
pubmed: 12125116
Clin Infect Dis. 2010 Nov 15;51(10):1192-8
pubmed: 20929356
Am J Trop Med Hyg. 2015 May;92(5):903-12
pubmed: 25778501
PLoS One. 2012;7(11):e49967
pubmed: 23185500
Lancet. 1985 Aug 3;2(8449):271
pubmed: 2862438
Transfusion. 2011 Mar;51(3):630-5
pubmed: 20849405

Auteurs

Kristin J Murphy (KJ)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Andrea L Conroy (AL)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Henry Ddungu (H)

Uganda Cancer Institute, Kampala, Uganda.

Ruchee Shrestha (R)

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Dorothy Kyeyune-Byabazaire (D)

Uganda Blood Transfusion Services, Kampala, Uganda.

Molly R Petersen (MR)

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Ezra Musisi (E)

Uganda Blood Transfusion Services, Kampala, Uganda.

Eshan U Patel (EU)

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Ronnie Kasirye (R)

MUJHU Research Collaboration, Kampala, Uganda.

Evan M Bloch (EM)

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Irene Lubega (I)

MUJHU Research Collaboration, Kampala, Uganda.

Chandy C John (CC)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Heather A Hume (HA)

Department of Pediatrics, CHU Ste-Justine, University of Montreal, Montreal, Canada.

Aaron A R Tobian (AAR)

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH